Lanean...
Emerging role of thalidomide in the treatment of gastrointestinal bleeding
Thalidomide was initially synthesised in 1954 and marketed as a sedative and antiemetic for morning sickness. It was withdrawn in 1961 due to the realisation that it was teratogenic with over 10 000 children born with congenital abnormalities. Since then it has been used for treatment of dermatologi...
Gorde:
| Argitaratua izan da: | Frontline Gastroenterol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868454/ https://ncbi.nlm.nih.gov/pubmed/29588836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2017-100870 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|